M Luengo
Overview
Explore the profile of M Luengo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hernandez L, Figueroa I, Riveros G, Luengo M, Munoz E
Polymers (Basel)
. 2025 Mar;
17(5).
PMID: 40076164
We studied the influence of different supporting electrolytes (TBAPF, TMAPF, TEAPF, TBAClO, and LiClO) on the morphology of PEDOT films electrochemically polymerized on screen-printed carbon electrodes, as part of which...
2.
Del Valle M, Gacitua M, Hernandez F, Luengo M, Hernandez L
Polymers (Basel)
. 2023 Mar;
15(6).
PMID: 36987228
Due to the energy requirements for various human activities, and the need for a substantial change in the energy matrix, it is important to research and design new materials that...
3.
Doussoulin A, Arancibia M, Saiz J, Silva A, Luengo M, Salazar A
NeuroRehabilitation
. 2017 Feb;
40(2):243-249.
PMID: 28222546
Background: Population ageing and changes in the epidemiological profile of neurological pathologies has resulted in an increase in patients with disabilities. Rehabilitation strategies such as Modified Constraint-Induced Movement Therapy (CIMTm)...
4.
Livianos L, Luengo M, Rodrigo G
Eur Psychiatry
. 2009 Aug;
10(5):266-7.
PMID: 19698352
No abstract available.
5.
Luengo M, Del Rio L, Pons F, Picado C
Eur Respir J
. 1997 Oct;
10(9):2110-3.
PMID: 9311512
Recent studies suggest that inhaled corticosteroids can adversely affect bone metabolism. The objective of this study was to evaluate the importance of these adverse effects in a case-control study. Bone...
6.
Picado C, Luengo M
Drug Saf
. 1996 Nov;
15(5):347-59.
PMID: 8941496
Osteoporosis is one of the most serious adverse effects experienced by patients receiving long term corticosteroid therapy. Bone loss occurs soon after corticosteroid therapy is initiated and results from a...
7.
Luengo M, Pons F, Martinez de Osaba M, Picado C
Thorax
. 1994 Nov;
49(11):1099-102.
PMID: 7831624
Background: Injectable calcitonin is effective in reducing spinal bone loss in steroid-dependent asthma but side effects are frequent. In contrast, a nasal spray presentation has been shown to be effective...
8.
Luengo M, Picado C, Del Rio L, Guanabens N, Montserrat J, Setoain J
Thorax
. 1991 Nov;
46(11):803-6.
PMID: 1771602
Background: Reduced bone mass predisposes patients to the development of vertebral fractures. Measurement of bone mass by non-invasive methods is used to detect patients with involutional osteoporosis at risk from...
9.
Luengo M, Picado C, Piera C, Guanabens N, Montserrat J, Rivera J, et al.
Eur Respir J
. 1991 Apr;
4(4):441-4.
PMID: 1855573
A secondary hyperparathyroidism resulting from decreased intestinal calcium (Ca) absorption has been proposed as a contributory factor to glucocorticoid-induced osteoporosis. Inhaled steroids do not usually suppress adrenal gland function unless...
10.
Luengo M, Picado C, Del Rio L, Guanabens N, Montserrat J, Setoain J
Am Rev Respir Dis
. 1990 Jul;
142(1):104-7.
PMID: 2195929
Sixty-two steroid-dependent asthmatics who had not received any form of treatment to prevent bone loss were studied during a 12-month period. Patients were randomly divided into two groups. Thirty-one patients...